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Abstract: Laser-enhanced thrombolysis by high intensity focused
ultrasound (HIFU) treatment was studied in vitro with bovine blood
clots. To achieve laser-enhanced thrombolysis, laser light was employed
to illuminate the sample concurrently with HIFU radiation, and ultra-
sound and laser parameters were optimized to achieve better thrombol-
ysis efficiency. The results indicated that the thrombolysis efficiency
increased when pulse length of HIFU wave, HIFU pressure, or laser flu-
ence increases. Also, with the presence of laser, an enhanced effect of
thrombolysis was observed.
VC 2013 Acoustical Society of America
PACS numbers: 43.80.Ev [CC]
Date Received: October 31, 2012 Date Accepted: January 2, 2013
1. Introduction
Catheter-based techniques have been extensively studied as an effective method to treat
deep venous thrombosis (DVT) clinically.1–6 However, these methods require a cathe-
ter to be placed within the blood clot, which is an invasive procedure. High intensity
focused ultrasound (HIFU) is one of the non-invasive methods to treat abnormal tis-
sues.7–9 In pulsed-HIFU with low duty cycle, which is used for thrombolysis, energy
deposition rates are low enough that temperature rises are well below the threshold for
thermal damage. Thus the effects of clot disruption are obtained more mechanically,
and cavitation effects are considered to make the biggest contribution during the pro-
cess.3,5,10–12 As a result, high acoustic peak negative pressure (as high as 19 MPa13) at
relatively low ultrasound frequencies such as 500 kHz or 1 MHz are used so that cavi-
tation can be effectively induced. However, at such low ultrasound frequencies, the
focal spot of the ultrasound field can be larger than 10 mm in length, which is larger
than the diameters of most veins. As a result, severe damage can occur to the sur-
rounding tissue and vessel walls.
Both microbubbles and thrombolytic drugs have been applied during
ultrasound-based thrombolysis. The addition of intravenously injected microbubbles
can enhance the effects of ultrasound and reduce the required energy for producing
ultrasound-mediated thrombolysis by decreasing cavitation threshold.3,12,14,15 Also, a
few of studies16 have shown that HIFU can improve thrombolysis while applying
thrombolytic agents by reducing the dosage of the drug and reducing the risk of hem-
orrhagic events, but increasing its efficacy. In addition, microbubbles and thrombolytic
drugs can be combined together for targeted drug delivery, drug transport accelera-
tion17–21 and eventually enhancing thrombolysis. However, the use of microbubbles
and thrombolytic drugs requires the systematic injection of foreign particles into the
blood stream, and would have a lot concerns regarding the toxicity, efficiency, etc.22
In our recent study,23 we found that when the laser system of photoacoustic
imaging (PAI) was running simultaneously with HIFU treatment, an enhanced heating
effect can be observed due to enhanced cavitation effects at a relatively low HIFU
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intensity. This finding potentially allows us to enhance HIFU without introducing for-
eign particles into the targeted tissue region. We expect that this discovery will be able
to get a wider range of applications, such as thrombolysis, due to the enhanced cavita-
tion effects.
In this study, we investigated the feasibility of laser-enhanced HIFU treatment
in the in vitro thrombolysis application. The effects of acoustic and laser parameters
(pulsed HIFU wave pulse length, pressure, and laser intensity) were assessed. More
importantly, the thrombolysis efficiency was measured with and without laser illumina-
tion to explore the enhancement on HIFU thrombolysis.
2. Materials and methods
2.1 Experimental system
The overall experimental arrangement is shown in Fig. 1. The laser source with a pulse
repetition rate of 10 Hz (5-ns pulse width) consists of a pulsed Q-switched, Nd:YAG
laser and a tunable optical parameter oscillator (OPO) laser (Surelite OPO PLUS, Con-
tinuum, Santa Clara, CA). The generated laser beam was formed into a ring-shaped illu-
mination on a condenser lens and refocused underneath a 5-MHz HIFU transducer
(SU-108-013, Sonic Concepts, Bothell, WA), which was mounted on the condenser lens
in the center hole. The 5-MHz HIFU transducer employed in this study has a 35 mm
focal length and 33 mm active diameter with a 50% bandwidth. The focal point
(6 dB) of HIFU transducer is 2.61 mm 0.51 mm 0.51 mm in water. A 10-MHz
focused ultrasonic transducer (V315, Olympus-NDT, Waltham, MA) (37.5 mm focal
length; 70% 6-dB fractional bandwidth), which was placed at a 90-deg angle with the
HIFU transducer and acted as a passive cavitation detector (PCD), was aligned to be
confocal with the HIFU transducer and the laser beam prior to HIFU treatments. The
HIFU source sine waves in burst mode were generated by a function generator
(HP33250A, Agilent Technologies, Santa Clara, CA), and amplified by a 50-dB radio
frequency amplifier (350L, ENI Technology, Inc., Rochester, NY), before they were sent
to the HIFU transducer to induce cavitation in the sample. The PCD signal was
received by a pre-amplifier (5072PR; Olympus-NDT, Waltham, MA) and captured by a
data acquisition card (GageScope, CS21G8-256MSn Gage, Lockport, IL) in a personal
computer. A10-MHz high-pass filter was used to remove contributions from the HIFU
fundamental and second harmonic frequencies to ensure that the detected signals were
mainly received from broadband acoustic emissions of cavitation. Both the 10- and
5-MHz transducers were immersed in a water tank filled with degassed water during the
treatment.
Fig. 1. System schematic.
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2.2 Clot preparation
Whole bovine blood mixed with CaCl2 in 6 mm inner diameter tygon tubing was
immersed in a 37 C water bath for 2 h and then stored at 4 C for up to 3 days to gen-
erate clots. Before the experiment, the clots cut into roughly cylindrical small pieces
with a diameter of 5 mm and a length of 5 mm were placed in a tygon tubing (6.25 mm
ID and 7.81 mm OD). The initial weight of blood clots were 205 6 41 mg (n¼ 155).
2.3 Experiment procedure
All experiments were conducted in a water container filled with degassed water. Each
blood clot were cut and weighted before the treatment and then placed in a clear tygon
tubing for exposure under HIFU transducer and laser light. During the sonication,
HIFU transducers, PCD detector and laser beams were driven by three-dimensional
(3-D) translation stages along x, y, and z directions. The predetermined speed of the
movement along x direction was 0.25 mm/s and the step size for y and z directions
were set to 0.5 and 1 mm according to the size of the clot and HIFU transducer focal
point. After the treatment, the clots were flushed with saline solution on a 400 lm pore
size filter for weighting. The difference between the initial clot weight and the weight
on the filter was used to calculate the weight loss, which is thrombolysis efficiency, and
expressed by percentage.
2.4 Ultrasound and laser parameters
The experiments were performed in three groups. Each group contained only one chang-
ing variable (HIFU pulse length, HIFU pressure, or laser fluence) with the other param-
eters remained constant to examine the influence of each variable on thrombolysis effi-
ciency. The treatment was repeated 5 times at each variable and performed both with
and without laser illumination for comparison.
To obtain HIFU pressure at the focal point, HIFU transducer was calibrated
in water using a standard hydrophone, and then a finite difference time domain
(FDTD)24 method was used to calculate the HIFU focal pressure. After these two
steps, the relation between function generator voltage input and HIFU focal pressure
can be found. In addition, the laser fluence at the sample surface was measured by a
power meter prior to the experiment.
The duty cycle of HIFU waves for all treatments was 10%. The laser wave-
length used in this study was 760 nm. During the treatment, the laser pulse with 10 Hz
repetition rate and the generation of HIFU waves from the function generator were
synchronized and triggered by the laser system. The pulsed laser and light wavelength
in the near infrared region were chosen to maximize the penetration depth while the
used laser intensity still complies with American National Standards Institute (ANSI)
safety standard for laser use.
3. Results and discussion
The mean thrombolysis efficiency was plotted as a function of pulse length in Fig. 2(a).
The HIFU negative pressure and laser fluence used in this group was 13.2 MPa and 27
mJ/cm2, respectively. This laser fluence at 760 nm laser wavelength was slightly higher
than the safety limit recommended by American National Standards Institute (ANSI),25
which is 26.4mJ/cm2. As we can see in the figure, longer HIFU pulse length yielded
higher thrombolysis efficiency until it reached a saturation stage. With laser, the satura-
tion point (800 ls pulse length) was reached earlier than it in the treatment without
laser (1000 ls). In the rising stage of the curves, the thrombolysis efficiency was greatly
enhanced by laser. At the pulse length of 800 ls, thrombolysis efficiencies with and
without laser were 62.8% and 41.0%, and thus the enhancement by laser was about
53.1%. To further investigate the possible reason of this enhancement, acoustic cavita-
tion signals were detected at each pulse length by the transducer. Figure 3 shows an
example of PCD output as a function of time both with and without laser at 600 ls
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HIFU pulse length. It is shown that cavitation signals are close to zero, and therefore
no inertial cavitation occurred when laser was off. However, when laser was presented,
the cavitation signals became much stronger, which indicated the occurrence of acoustic
cavitation. After detecting PCD signals at each HIFU pulse length, it was observed
that the cavitation occurred in the treatments with laser at 400 ls pulse length. How-
ever, without the laser illumination, the cavitation signals were very weak until the
pulse length reached 1000 ls. As we know, cavitation has been demonstrated to enhance
Fig. 3. PCD output as a function of time without (a) and with (b) laser at 600 ls HIFU wave pulse length.
Fig. 2. Thrombolysis efficiency correlated with HIFU wave pulse length (a), HIFU pressures (b), and laser flu-
ence (c) in the treatment with and without laser radiation.
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thrombolysis effect. Therefore the possible reason of the enhancement of HIFU throm-
bolysis treatment in this study was the laser-enhanced acoustic cavitation.
To test the influence of HIFU negative pressure on thrombolysis efficiency,
HIFU pulse length (1000 ls) and laser fluence(27 mJ/cm2) were fixed. It is indicated in
Fig. 2(b) that at 5 and 7 MPa HIFU negative pressure, the thrombolysis efficiency were
only about 21.1% 6 3.0% and 18.6% 6 3.9%. However, as the HIFU pressure increases,
a maximum of 74.2% 6 2.8% clot weight loss can be reached. Also, treatment with
ultrasound alone produced less thrombolysis than that with the presence of laser. In
addition, similar as the PCD detection in different HIFU pulse lengths measurements,
acoustic cavitation can be observed at 7 and 9 MPa with and without laser. Thus, simi-
larly, it is demonstrated again that the laser illumination has successfully lowered cavi-
tation threshold and therefore enhanced the HIFU thrombolysis efficiency.
The effect of increasing laser fluence on thrombolysis was also examined as
shown in Fig. 2(c). The HIFU negative pressure was 9.18 MPa and HIFU wave pulse
length was 1000 ls in these treatments. Acoustic cavitation threshold was observed at
laser fluence of 16 mJ/cm2. When laser fluence was smaller than 16 mJ/cm2, thrombol-
ysis efficiency was low. However, as the laser fluence increased, a steep increase in
thrombolysis efficiency was observed.
4. Discussion and conclusions
This study investigated the feasibility of using laser enhanced cavitation to enhance
HIFU thrombolysis without the addition of any thrombolytic agents or microbubbles.
Three important ultrasound and laser parameters (HIFU wave pulse length, HIFU
pressure, and laser fluence) were chosen to test their influence on thrombolysis effi-
ciency. As the pulse length, HIFU pressure, and laser fluence increases, better throm-
bolysis efficiency can be obtained. The optimal parameters were a pulse length of
1000 ls, HIFU negative pressure of 13 MPa and under 27 mJ/cm2 laser radiation, at
which a maximum thrombolysis efficiency (74.2% 6 2.8%) were achieved.
In addition, significant enhancement of thrombolysis efficiency was observed
with laser illumination. Laser enhanced cavitation was considered to be a primary fac-
tor in the enhancement of HIFU thrombolysis treatment because it is shown that cavi-
tation threshold was greatly reduced when laser was running concurrently with HIFU
treatment. Generally, laser light may induce cavitation through heating or chemical
breakdown. However, in our study, the laser fluence was under the ANSI safety limit
and suggested that significant heating or chemical breakdown by laser light alone was
unlikely. Therefore the combination of ultrasound and laser light could be the key fac-
tor for cavitation. A possible mechanism is that there is an instantaneous heating on
the nano-second scale during laser illumination. When this instantaneous heating is
coupled with negative ultrasound pressure, cavitation will be induced.
We have shown in our previous study23 that laser enhanced HIFU treatment
can be used in soft tissue thermal ablation. In this study, the results implied that this
technique has successfully shown another potential application in the thrombolysis
field. More future work is needed to evaluate its in vivo and clinical feasibility and
potential risk of injury of vessel wall and surrounding tissue.
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